Feeds
Swiss drug developer Roche said Friday six cases of patients with heart failure symptoms prompted a halt to enrollment in a National Cancer Institute sponsored study of its blockbuster drug Avastin.
Swiss pharmaceutical giant Roche Holding AG said Monday that it has had reports of 13 cases of pandemic swine flu becoming resistant to Tamiflu, which it calls a very low percentage.
Health officials have told governments they can keep Tamiflu for longer to help fight the swine flu pandemic.
Pharmaceuticals maker Roche Holding AG on Thursday posted a 29 percent drop in six-month net profit because of costs related to the takeover of California-based Genentech. However, sales were strong, helped by the popularity of antiviral Tamiflu in the face of the swine flu pandemic.
Roche said Friday it will stop selling the acne drug Accutane as sales of the treatment continue falling amid competition from less expensive generic versions.
Pharmaceuticals maker Roche Holding AG reported Thursday a 7 percent increase in first quarter sales thanks to strong demand for its cancer drugs, anti-virals and eye products.
Swiss drugmaker Roche plans to keep the chairman and chief executive of newly acquired biotech drug developer Genentech on board as chairman of the unit and named a Roche executive as its new CEO, the company said Tuesday.
Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S.-based cancer drug partner.
Genentech's board of directors is close to striking a $95-per-share sale to cancer drug partner Roche, according to a report by the Wall Street Journal.
Swiss drug developer Roche boosted its hostile tender offer for biotechnology pioneer Genentech Inc. to $93 per share Friday, raising the total offer value to $45.7 billion, after its initial offer failed to pick up much support from shareholders.
Genentech Inc. on Monday urged shareholders to reject a $42 billion hostile buyout bid from Swiss drugmaker Roche.
Swiss drugmaker Roche on Monday officially launched its $42 billion hostile offer for the 44 percent of Genentech Inc. it doesn't already own.
Roche's hostile bid for Genentech Inc., which became official late Monday, revealed just how far apart the companies are on valuing Genentech, with the biotechnology pioneer at one point asking for $112 per share, far more than Roche's initial bid.
Swiss drugmaker Roche Holding AG surprised Wall Street with plans for a lower-than-expected and hostile $42.1 billion buyout offer for Genentech Inc. Friday, a move some consider a tactic to force negotiations with the biotechnology behemoth.
Swiss pharmaceutical giant Roche Holding AG plans to cut 780 positions over the next two to three years, a spokeswoman said Friday,
Federal regulators said Tuesday they have approved a new HIV test that screens for two, less common forms of the virus.
A jury has ordered drugmaker Roche to pay nearly $13 million to three patients who claim they developed a chronic bowel disorder because of the company's acne drug Accutane.
Biotechnology giant Genentech Inc. rejected a $43.7 billion buyout offer from its majority owner Roche on Wednesday but said it is open to a higher takeover bid.
Biotechnology pioneer Genentech Inc. mulled Roche Holding's $43.7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more.
Swiss pharmaceutical maker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc., seizing the opportunity offered by the weak U.S. dollar to grab a bigger share of earnings from such Genentech drugs as the blockbuster cancer treatment Avastin.
Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.
Regulators are exploring whether organ transplant drugs made by Roche and Novartis increase the risk of an often-fatal neurological disease.
China's drug watchdog announced Saturday it has suspended the sale of a drug used to treat acute leukemia and rheumatoid arthritis in the latest move to hit the country's scandal-ridden drug industry.
Experts question use of Tamiflu: report - Yahoo! News["Governments around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge," she said.] Tami about it.
Also in that Room: Democratic Biotech-Paid Whores In my last post, I showed you what a roomful of Republican biotech-paid whores looks like. But in that same room are the following Democratic biotech-paid whores.
What a Roomful of Republican Biotech-Paid Whores Looks Like As the NYT reported earlier today, Genentech/Roche wrote a Republican script and a Democratic script for its parrots to enter into the Congressional Record.
NYT: 22 Republicans, 20 Democrats Used Lobbying Firm's Statements In House Health Care SpeechesIn the official record of the historic House debate on overhauling health care, the speeches of many lawmakers echo with similarities. Often, that was no accident.
12 Monkeys and Swine flu: Warning shotIt is scandal he said to Spiegel, 'the health authorities have fallen for a campaign from the pharmaceutical companies, who simply want to earn money with an alleged threat'.
I received an email from the White House's advisor on Homeland Security John O Brennan stating that he was passing along a message from Kathleen Sebelius, Secretary of Health and Human Services, Janet Napolitano, Secretary of Homeland Security, and Arne Duncan, Secretary of Educa …
Doubts Raised About Effectiveness of TamifluWith the declaration of a worldwide swine flu pandemic near, serious questions are being raised about the effectiveness of Tamiflu, the drug widely considered the first line of defence against a deadly virus.
Empathy comes naturally to childrenWhen children see others in pain, their brains respond as if it were happening to them, U.S. researchers said on Friday.
The Diarrhea Diet: GlaxoSmithKline's Crap Your Pants Diet Pill But not all diet products feature the "oily bowels" and "anal leakage" that made alli an instant success on the comic circuit.
Pharmacists sign with Big Pharma to promote anti-fat drugThe controversial anti-fat drug Xenical has been given a new lease of life, with the announcement of a special financial arrangement between pharmacists and Swiss drug giant Roche.
Open blue: barbs fly over new surface - Australian OpenCriticism mounts over the New plexipave courts at the Australian open, as they may not to live up speed claims. They may even be slower than the Rebound Ace courts they replaced, and there have already been two injuries, Mark Philippoussis and Jelena Dokic.
Roche loves the surface his charge so despises - Australian OpenTony Roche - the coach of Lleyton Hewitt, publicly endorses the New Generation Rebound Ace Club product which was tossed out in favour of Plexicushion for this years Australian open. He has even installed it in his own home.
Hewitt in Favour of New SurfaceHewitt expresses his support for the new surface Plexicushion which ousted Rebound Ace at this years Australian Open. He hopes it will reduce injuries like hips and lower back areas.
FDA Wants Warnings on Two Flu DrugsFDA Wants Warnings About Possible Bizarre Behavior in Kids That Get 2 Widely Used Flu Drugs. Government health regulators recommended adding label precautions about neurological problems seen in children who have taken flu drugs made by Roche and GlaxoSmithKline.
FDA staff urge psych warnings for two flu drugsU.S. Food and Drug Administration staffers are recommending new warnings about psychiatric events observed in some patients taking Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, according to documents released on Friday.
Abnormal behavior reported in children who took TamifluAbnormal behavior reported in children who took Tamiflu The FDA is looking into reports of abnormal behavior in kids who took Tamiflu.
Roche eyes off Aussie OpenTony Roche has targeted the Australian Open title after being appointed Lleyton Hewitt's coach for the next 18 months.
Roche confirms Avastin efficacy for colorectal cancerSwiss pharmaceuticals group Roche said its Avastin drug showed promising efficacy in terms of progression-free survival as first-line treatment in colorectal cancer patients when added to Folfiri.
UPDATE 1-Roche sees more Europeans using low-dose Avastin | Health | ReutersPhysicians in Europe are likely to use the lower dose of Avastin in treating patients with lung cancer, while U.S. doctors take a more mixed approach, Roche Holding AG's (ROG.VX: Quote, Profile, Research head of pharmaceuticals said on Monday.
Shares of Anemia Drug Makers Slide as Medicare Threatens to Cut Reimbursement - New York TimesAmgen shares were battered again yesterday after Medicare proposed to sharply curtail reimbursement for the company's biggest selling product, the anemia drug Aranesp.
Amgen suffers another round of negative newsOn Friday, the Thousand Oaks-based biotech giant received a series of bad news that follows negative developments in recent months.
Roche's Mircera Wins EU Backing After U.S. DelayRoche Holding AG's new anemia treatment Mircera, delayed a week ago by U.S. regulators, won a positive opinion in Europe when a panel of scientists recommended it for approval.
Roche gets US FDA's approval letter for anaemia drugRoche announced that the US Food and Drug Administration (FDA) has issued an approvable letter for Mircera for the treatment of anaemia associated with chronic renal failure including patients on dialysis and patients not on dialysis.
CDC says gonorrhea is drug-resistantCDC says gonorrhea is drug-resistant The sexually transmitted disease gonorrhea is now among the "superbugs" resistant to common antibiotics, leading U.S. health officials to recommend wider use of a different class of drugs to avert a public health crisis.....
Looking for geothermal power in a deep heat mining project, interested parties dug a borehole 5 kilometers into the ground close to the town of Basel in NW-Switzerland, home to pharmaceutical companies like Roche and Novartis.
Log In | Register
